Leading experts discuss the pros and cons of government regulations and explain how they affect everyday life for Americans.
April 13, 2023
AI is increasingly used both in the public and private sectors for facial recognition, dataset analysis, risk and performance predictions, and much more, though how companies use it and the actual input it has can be unclear. At an in-person luncheon, an expert panel discussed the tensions surrounding the issues of AI and employment law.
Listen to this podcast
April 13, 2023
At an in-person luncheon, EEOC Commissioner Keith Sonderling delivered a keynote address on issues concerning AI’s entrance into the Labor and Employment space.
Listen to this podcast
April 3, 2023
Experts discuss the origins as well as the potential benefits and risks of this innovation in government contracting policy.
Listen to this podcast
March 9, 2023
A panel of experts discusses what Section 230 permits and doesn’t permit—a question now before a number of courts, including the U.S. Supreme Court in Gonzalez v. Google.
Listen to this podcast
March 8, 2023
This episode is a live recording of a panel of antitrust law experts examining recent developments and debating what might come next at the FTC.
Listen to this podcast
March 8, 2023
In late February 2023, the FDA released its responses to the December 2022 Regan-Udall Foundation reports on the FDA’s Human Foods and Tobacco programs.
Listen to this podcast
March 8, 2023
In January 2023, the FTC announced a proposed rule that would ban noncompete agreements across most of the U.S. economy – a move President Biden lauded in his recent State of the Union address.
Listen to this podcast
March 7, 2023
In this podcast featuring Tom Miller, he lays out a brief summary of how we got to where we are with regards to Medicaid.
Listen to this podcast
February 17, 2023
Last November, the Federal Trade Commission accepted comments on its proposal to start a rulemaking related to “Commercial Surveillance” – the agency’s newly minted term for any and all business use of data about customers.
Listen to this podcast
February 17, 2023
In November 2022, the Alliance Defending Freedom (ADF) filed a federal lawsuit against the FDA on behalf of the AHM and others, challenging the FDA’s 2000 decision to legalize mifepristone and misoprostol, two drugs often used in conjunction as chemical abortifacients.
Listen to this podcasta venture of
The Federalist Society
1776 I Street, NW, Suite 300
Washington, DC 20006
fedsoc.org
[email protected]
